Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

Clinical trial NCT06287775 · RECRUITING

Trial details

NCT number: NCT06287775
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Extensive Stage Lung Small Cell Carcinoma Stage IV Lung Cancer AJCC v8

Start date: 2025-04-08
Primary completion: 2029-07-25
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.